Blake E. Michener

Array ( [id] => 2926049 [patent_doc_number] => 05219566 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-06-15 [patent_title] => 'Immunoprophylactic polypeptides for schistosomiasis' [patent_app_type] => 1 [patent_app_number] => 7/725804 [patent_app_country] => US [patent_app_date] => 1991-07-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 12 [patent_no_of_words] => 5409 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/219/05219566.pdf [firstpage_image] =>[orig_patent_app_number] => 725804 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2856850 [patent_doc_number] => 05112950 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1992-05-12 [patent_title] => 'Factor VIII analog, preparation process, and pharmaceutical composition containing it' [patent_app_type] => 1 [patent_app_number] => 7/723666 [patent_app_country] => US [patent_app_date] => 1991-06-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 4 [patent_no_of_words] => 3330 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/112/05112950.pdf [firstpage_image] =>[orig_patent_app_number] => 723666 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2931012 [patent_doc_number] => 05196323 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-03-23 [patent_title] => 'Process for preparing and purifying alpha-interferon' [patent_app_type] => 1 [patent_app_number] => 7/713618 [patent_app_country] => US [patent_app_date] => 1991-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 19 [patent_no_of_words] => 9955 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 131 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/196/05196323.pdf [firstpage_image] =>[orig_patent_app_number] => 713618 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2912095 [patent_doc_number] => 05178860 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-01-12 [patent_title] => 'Adjuvant complexes and vaccine made therefrom' [patent_app_type] => 1 [patent_app_number] => 7/611543 [patent_app_country] => US [patent_app_date] => 1990-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3999 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/178/05178860.pdf [firstpage_image] =>[orig_patent_app_number] => 611543 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2819717 [patent_doc_number] => 05169628 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1992-12-08 [patent_title] => 'Chimeric glycoproteins containing immunogenic segments of human parainfluenza virus type 3' [patent_app_type] => 1 [patent_app_number] => 7/582891 [patent_app_country] => US [patent_app_date] => 1990-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9268 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/169/05169628.pdf [firstpage_image] =>[orig_patent_app_number] => 582891 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2825733 [patent_doc_number] => 05128129 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1992-07-07 [patent_title] => 'Infectious bovine rhinotrachetis virus mutants, vaccines containing same, methods for the production of same and methods for the use of same' [patent_app_type] => 1 [patent_app_number] => 7/591999 [patent_app_country] => US [patent_app_date] => 1990-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 11 [patent_no_of_words] => 21452 [patent_no_of_claims] => 58 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/128/05128129.pdf [firstpage_image] =>[orig_patent_app_number] => 591999 [rel_patent_id] =>[rel_patent_doc_number] =>)